Clinical Pathology Department, Medical School, University of Campinas, Campinas, SP, Brazil.
Int J Cardiovasc Imaging. 2010 Jan;26(1):27-34. doi: 10.1007/s10554-009-9498-2. Epub 2009 Oct 30.
To determine whether hyperalphalipoproteinemia modifies carotid intima-media thickness (cIMT) and/or influences the relationship of clinical and biochemical parameters with cIMT. This study was conducted on 169 asymptomatic individuals, classified as hyperalphalipoproteinemic (Hyper-A) (Hyper-A, n = 71, HDL-C > or =68 mg/dL) and controls (CTL) (CTL, n = 98, HDL-C >32 and <68 mg/dL). Enzymatic, nephelometric and ultracentrifugation methods were used for biochemical determinations. Hepatic lipase (HL), lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP) and phospholipids transfer protein (PLTP) activities were measured by radiometric exogenous methods. The prevalence of dyslipidemia, hypertension, smoking, sedentariness, postmenopausal women, coronary artery disease (CAD) and familial history of CAD were determined. High resolution beta-mode carotid ultrassonography was performed. The Hyper-A group was older and had higher frequencies of hypercholesterolemia (40%), hypertension (31%), sedentariness (37%) and postmenopausal women (1%). In Hyper-A individuals, the mean cIMT after adjustment for age and gender was similar between the groups (0.85 +/- 0.24 mm Hyper-A versus 0.69 +/- 0.17 mm CTL). In multivariate models, age was a significant predictor of cIMT in Hyper-A (R (2) = 0.04, p < or = 0.001), independently of other clinical or biochemical factors. In contrast to CTL, where age (R (2) = 0.63 p < or = 0.001), male sex (R (2) = 0.03, p < or = 0.001), blood pressure (R (2) = 0.006, p < or = 0.001) and HDL-C (R (2) = 0.02, p < 0.022) accounted for the cIMT variations. Despite an increased prevalence of cardiovascular risk factors in Hyper-A and resistance of carotid thickness to modulation by metabolic and anthropometric factors (except age), the similarity in cIMT between Hyper-A and healthy individuals emphasizes the atheroprotective effects of HDL.
为了确定高α脂蛋白血症是否会改变颈动脉内膜中层厚度(cIMT),以及是否会影响临床和生化参数与 cIMT 的关系。本研究纳入了 169 名无症状个体,分为高α脂蛋白血症(Hyper-A)组(n = 71,HDL-C≥68mg/dL)和对照组(CTL)(n = 98,HDL-C>32mg/dL 且<68mg/dL)。采用酶法、比浊法和超速离心法进行生化测定。采用放射性外源性方法测定肝脂酶(HL)、脂蛋白脂酶(LPL)、胆固醇酯转移蛋白(CETP)和磷脂转移蛋白(PLTP)的活性。确定血脂异常、高血压、吸烟、久坐、绝经后妇女、冠心病(CAD)和 CAD 家族史的发生率。进行高分辨率β模式颈动脉超声检查。Hyper-A 组年龄较大,且患有高胆固醇血症(40%)、高血压(31%)、久坐(37%)和绝经后妇女(1%)的比例较高。在 Hyper-A 个体中,校正年龄和性别后,两组的平均 cIMT 相似(0.85±0.24mm Hyper-A 与 0.69±0.17mm CTL)。多元模型分析显示,年龄是 Hyper-A 个体 cIMT 的显著预测因子(R²=0.04,p<0.001),独立于其他临床或生化因素。与 CTL 不同,年龄(R²=0.63,p<0.001)、男性(R²=0.03,p<0.001)、血压(R²=0.006,p<0.001)和 HDL-C(R²=0.02,p<0.022)是 cIMT 变化的决定因素。尽管 Hyper-A 个体中心血管危险因素的发生率增加,颈动脉厚度对代谢和人体测量因素的调节有抵抗性(除年龄外),但 Hyper-A 个体与健康个体之间 cIMT 的相似性强调了 HDL 的抗动脉粥样硬化作用。